期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess:A case report 被引量:1
1
作者 Heng Yeh Chia-Jung Kuo +5 位作者 Ren-Chin Wu Chien-Ming Chen Wen-Sy Tsai Ming-Yao Su Cheng-Tang Chiu Puo-Hsien Le 《World Journal of Gastroenterology》 SCIE CAS 2021年第5期442-448,共7页
BACKGROUND Fistula and intraabdominal abscess are common complications of Crohn’s disease(CD),but complex rectal fistula with abscess formation is rare.Tumor necrosis factor antagonists combined with percutaneous dra... BACKGROUND Fistula and intraabdominal abscess are common complications of Crohn’s disease(CD),but complex rectal fistula with abscess formation is rare.Tumor necrosis factor antagonists combined with percutaneous drainage or surgical intervention is optimal treatment for fistulizing CD with intraabdominal abscess.There is no study showing the efficacy of vedolizumab in such complicated condition.CASE SUMMARY A 47-year-old man has decompensated liver cirrhosis,Child B.He suffered from abdominal pain,bloody diarrhea,fever,and body weight loss.CD with rectoprostatic fistula,rectopresacral fistula,presacral abscess and cytomegalovirus(CMV)infection were noted.He received antibiotics,anti-viral therapy,transverse colostomy and vedolizumab treatment.Six months later,he had deep remission and complete fistula tracts closure.CONCLUSION Early vedolizumab and stool diversion are effective and safe in treating CD with complex rectal fistula with abscess formation. 展开更多
关键词 Vedolizumab Crohn's disease rectoprostatic fistula Rectal presacral fistula Presacral abscess Case report
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部